Holds one active US DMF for etoricoxib, filing since 2012. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds one active US DMF for etoricoxib, filing since 2012. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds one active US DMF for etoricoxib, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Registered with SFDA (Saudi Arabia) for etoricoxib. Its GMP is recognised in 7 markets.
Registered with SFDA (Saudi Arabia) for etoricoxib. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for etoricoxib.
Registered with SFDA (Saudi Arabia) for etoricoxib.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Etoricoxib manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free